Frontlight ResearchEarly access
Trial site
The Oncology Institute of Hope and Innovation
- 4running trials
- 7closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Terminated3 trials
- Lead sponsor
- Pfizer2 trials
- Takeda2 trials
- ADC Therapeutics S.A.1 trial
- Ariad Pharmaceuticals1 trial
- Daiichi Sankyo1 trial
- and 4 more
Running trials
Active, not recruiting
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
Completed
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Completed
Terminated
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Site data: ClinicalTrials.govUpdated 18 Nov 2026